FSX : BSX.F

Boston Scientific Corporation

$41.22 EUR

$2.11 (5.4%)

Volume
2.5K
Average Volume
170
Market Capitalization
$61.27B
P/E Ratio
18.84
Dividend Yield
0.00%
Price Target
Year High
$93.00
Year Low
$36.59
Day High
—
Day Low
—
Payout Ratio
$0.00
Current Ratio
$1.90
Company Overview

FSX

Michael F. Mahoney

Medical - Devices

Healthcare

BSX.F

59000

US

EUR

https://www.bostonscientific.com

508 683 4000

101137107

N/A

Liquidity Metrics

0.43

1.90

1.22

0.33

0.00

Sales & Valuation

$20.08B

3.31

2.67

20.18

2.33

Profitability

$1.94

$2.89B

17.47%

18.39%

15.29%

8.27%

P/E Metrics

18.84

0.41

0.41

Analyst Price Target & Rating

Sell

2/5

44 Analysts

%

Financial Health Scores

3.30

6/9

$4.1B

$44.18B

$18.18B

$3.77B

Key Metrics (TTM)

No key metrics data available.

Company Executives
Name Title
Adam Smith General Manager of Global Sales & Marketing
Paudie O'Connor Executive Vice President of Global Operations
Jonathan Monson Executive Vice President & Chief Financial Officer
Vance R. Brown EVP, General Counsel & Corporate Secretary
Brenda Becker Senior Vice President of Global Government Affairs
Emily Woodworth Senior Vice President, Global Controller & Chief Accounting Officer
Miriam O'sullivan Senior Vice President & Chief Human Resources Officer
Arthur Crosswell Butcher Executive Vice President and Group President of MedSurg & Asia Pacific
Joseph Fitzgerald Executive VP & Group President of Cardiovascular
Michael F. Mahoney Chairman, President & Chief Executive Officer
Poll Results

No votes yet today — be the first to share your view!

About Boston Scientific Corporation (FSX:BSX.F) Stock

Founded in 1979 and headquartered in Marlborough, Massachusetts, Boston Scientific Corporation is a global leader in designing, manufacturing, and marketing advanced medical devices. The company's products cater to a wide range of interventional medical specialties worldwide, organized primarily under its MedSurg and Cardiovascular segments. The MedSurg division focuses on technologies for diagnosing and treating gastrointestinal, pulmonary, urological, and pelvic conditions. Within the expansive Cardiovascular segment, Boston Scientific provides solutions for cardiac rhythm management, including implantable defibrillators, pacemakers (both standard and cardiac resynchronization therapy models), and remote patient monitoring systems. It also offers sophisticated tools for addressing heart ... rate and rhythm disorders, such as 3-D cardiac mapping, ablation, diagnostic, and intracardiac ultrasound catheters, alongside necessary accessories. Furthermore, the company's portfolio extends to neuromodulation, featuring spinal cord stimulators for chronic pain, indirect decompression systems, and deep brain stimulation systems. Its interventional cardiology products are crucial in treating coronary artery disease and aortic valve conditions. Lastly, Boston Scientific is a key provider of devices for arterial and venous diseases and cancer therapies, encompassing stents, balloon catheters, guidewires, atherectomy and thrombectomy systems, peripheral embolization tools, radioactive microspheres, cryotherapy ablation systems, and various micro and drainage catheters.

Boston Scientific beats second quarter expectations, raises full-year outlook

2026-07-29 08:07:00

Boston Scientific Corp (NYSE:BSX, XETRA:BSX) reported second quarter results that exceeded analyst expectations for revenue and adjusted earnings, while...

Frequently Asked Questions

What is the current Boston Scientific Corporation (BSX.F) stock price?

Boston Scientific Corporation(FSX:BSX.F) stock price is $41.22 in the last trading session. During the trading session, BSX.F stock reached the peak price of $93 while $36.59 was the lowest point it dropped to. The percentage change in BSX.F stock occurred in the recent session was 5.4% while the dollar amount for the price change in BSX.F stock was $2.11.

BSX.F's industry and sector of operation?

The FSX listed BSX.F is part of Medical - Devices industry that operates in the broader Healthcare sector.

Who are the executives of BSX.F?

Adam Smith | General Manager of Global Sales & Marketing
Paudie O'Connor | Executive Vice President of Global Operations
Jonathan Monson | Executive Vice President & Chief Financial Officer
Vance R. Brown | EVP, General Counsel & Corporate Secretary
Brenda Becker | Senior Vice President of Global Government Affairs

How many employees does BSX.F have?

Number of BSX.F employees currently stands at 59000. BSX.F operates from 300 Boston Scientific Way, Marlborough, MA 01752-1234, US.

Link for BSX.F official website?

Official Website of BSX.F is: https://www.bostonscientific.com

How do I contact BSX.F?

BSX.F could be contacted at phone #508 683 4000 and can also be accessed through its website. BSX.F operates from 300 Boston Scientific Way, Marlborough, MA 01752-1234, US.

How many shares of BSX.F are traded daily?

The average number of BSX.F shares traded daily for last 3 months was 170.

What is the market cap of BSX.F currently?

The market value of BSX.F currently stands at $61.27B with its latest stock price at $41.22